发布时间:2019-04-23 07:46 原文链接: PreparationOfPeripheralBloodCellsForChromosomeAnalysis

实验概要

Lymphocytes  are differentiated cells which normally do not undergo subsequent cell  divisions. By culturing lymphocytes in the presence of a mitogen  (KARYOMAX® Phytohemagglutinin (M-Form) (PHA), Cat. No. 10576), they are  stimulated to replicate their DNA and enter into mitosis. After an  optimum time of the cells being cultured (46 h for a newborn and 68 h  for an adult), a mitotic inhibitor, KARYOMAX COLCEMID® Solution (Cat.  No. 15210 or 15212), is added to the lymphocyte culture for 20 min.

The  addition of COLCEMID to dividing cells acts to prevent the synthesis of  spindle fibers and, therefore, to stop mitosis in metaphase. Metaphase  is the optimum phase of mitosis for microscopically visualizing the  chromosomes. By submitting cells to a hypotonic solution and a series of  fixation steps, metaphase chromosomes can be microscopicallyobserved  and analyzed.

As  a quality control measure, each lot of Phytohemagglutinin is tested as a  chromosome reagent for the examination of metaphase spreads used for  cytogenetic studies. This reagent is evaluated by supplementation to an  approved, non-phytohemagglutinin containing chromosome medium. These  samples are then supplemented with freshly collected human peripheral  blood and have been found to be acceptable in their ability to produce  blastogenesis with human lymphocytes when compared to a previously  tested control.

主要试剂

Phytohemagglutinin (M Form) (PHA), Liquid [Details:Life Technologies Cat# 10576-015]

PB-MAX™ Karotyping Medium (1X), Liquid [Details:Life Technologies Cat#12557-013]

KaryoMAX® Colcemid™ Solution, Liquid (10 µg/ml), in HBSS [Details:Life Technologies Cat#15210-040]

KaryoMAX® Colcemid™ Solution, Liquid (10 µg/ml), in PBS [Details:Life Technologies Cat#15212-012]

实验步骤

1.        The required volume of peripheral blood is collected aseptically in a sodium heparinized vacutainer tube or syringe.

2.         Add 10 ml of either PB-MAX Karyotyping Medium or KARYOMAX Peripheral  Blood Karyotyping Medium to each sterile T-25 flask to be set up for the  assay.

3.        Add 0.75ml blood to each tube.

4.        Incubate flask in CO2 incubator for 48 to 68 h with caps loose.

5.        Add 0.05-0.1 ug/ml COLCEMID to each flask for a 15 minute incubation.

6.        After 15 min, transfer flask contents to a 15 ml centrifuge tube and spin down at 1,200 rpm for 5 min.

7.        Remove supernatant and resuspend pellet.

8.         Add 10 ml of 0.068 M KCl to pellet and gently mix. Allow to sit at room  temperature for 15 min. Add 0.5 ml of fixative (three parts absolute  methanol to none part glacial acetic acid). Gently mix with pipette.

9.         Centrifuge for 5 min at 1,200 rpm. Aspirate off supernatant. Add 10 ml  of fixative, mix, and let sit at room temperature for 10 min.

10.    Repeat centrifugation step. Add 5 ml of fixative, mix, and let sit for 10 min atroom temperature.

11.    Centrifuge and aspirate off supernatant. Add 5 ml of fixative and incubate for 10min at 4°C.


相关文章

SETD2调控骨髓增生异常综合征转白血病的新机制

研究阐明了SETD2在调控骨髓增生异常综合征(MDS)向急性髓系白血病(AML)转化过程中的作用机制,为MDS临床治疗提供了理论基础和潜在靶标。MDS是最常见的髓系恶性肿瘤之一,是起源于造血干细胞的一......

Blood:如何从根源断绝癌症的发生?

为什么有些癌症治疗之后仍会复发?有时候,癌症的相关治疗可以有效地将癌细胞消除到无法检测的水平,但是,如果停止治疗,癌症可能会复发。例如,在用酪氨酸激酶抑制剂药物治疗慢性粒细胞白血病患者是就会出现停药后......

Blood:中美科学家揭示化疗导致耐药性白血病复发之谜

化疗已使最常见的儿童期癌症---急性淋巴细胞白血病(ALL)---成为最可治愈的癌症之一,但是科学家们有证据表明这种治疗也可能使某些患者复发。在一项新的研究中,来自中国和美国的研究人员报道由治疗引起的......

研究发现肝脏肿瘤逃脱自然杀伤细胞免疫监视新机制

自然杀伤细胞(Naturalkillercells,NKcells)是一种效应性淋巴细胞,在人体抗肿瘤过程中发挥重要作用,但是,仍然有一些肿瘤细胞能够逃避机体NK细胞的攻击,逐步发生发展,侵袭转移,严......

StemCellsDev:发现骨形成的新型调节因子

研究人员发现了小鼠体内一种新的转录因子可以帮助调节间充质干细胞(mesenchymalstemcells,MSCs)分化为骨的过程。目前科学家们对于骨细胞分化的研究并不深入,而MSCs则是再生医学领域......

抵抗白血病的新武器

在一项新的研究中,来自美国俄亥俄州大学的DaniloPerrotti和同事证实一种叫做FTY720的药物能够抑制由癌症蛋白BCR-ABL导致的白血病小鼠模型的病情。由于这种药物还能够诱导从白血病患者获......

中山大学最新《Blood》文章解析细胞因子新发现

来自中山大学有害生物控制与资源利用国家重点实验室(StateKeyLaboratoryofBiocontrol,原生物防治国家重点实验室),基因工程教育部重点实验室(KeyLaboratoryofGe......